Study of elecoglipron for chronic kidney disease
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests an investigational medicine called elecoglipron for people with chronic kidney disease. It aims to see if it can improve kidney health compared to a placebo (inactive pill) and may be an option for those already on standard blood pressure and kidney protective medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults with chronic kidney disease, including a urine protein level of 30 mg/g or higher and an estimated kidney function (eGFR) of 20 or more (units will be checked)
- Must be on a stable, maximally tolerated dose of an ACE inhibitor or ARB (kidney protective blood pressure medicines) for at least 4 weeks before screening
- Body mass index (BMI) of 23 or higher
- No history of type 1 diabetes
- Recent blood sugar (HbA1c) less than 10%
- No active treatment for diabetic eye disease (retinopathy or macular edema)
- No more than one severe low blood sugar event in the last 6 months and no unawareness of low blood sugar
- No heart attack, stroke, or major heart procedure in the last 3 months
- No significant stomach or intestinal condition, and not taking medicines that affect stomach emptying
- No history of pancreatitis or certain types of thyroid cancer (medullary thyroid cancer or MEN2)
- Not currently participating in another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if empagliflozin, a daily pill, is safe and helps children ages 2–17 with chronic kidney disease (CKD). Your child may be eligible if they have reduced kidney function and elevated protein in their urine, and are already on stable kidney treatments.
This study tests HRS-7535, a new oral tablet that may help protect kidneys in people with chronic kidney disease. GLP-1 medications were originally developed for diabetes but may also benefit kidney function and overall health.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This trial tests if orforglipron can reduce the risk of heart attack, stroke, or kidney failure in people with heart disease or chronic kidney disease.
This trial tests a new medicine called elecoglipron, taken alone or with another diabetes drug (dapagliflozin), to see if it helps control blood sugar better than a placebo. It may be an option if your current treatment isn't working well enough.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.